Team Portfolio Raise Read Contact

F4/OrbiMed Advisors/Activity

OrbiMed Advisors Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

3 investments· MAR 2026 – APR 2026Show all

Investment

Led $50M financing for Nucleus RadioPharma to expand radiopharmaceutical manufacturing capacity.

Nucleus RadioPharma

Nucleus RadioPharma OrbiMed Advisors

tcbmag.comAPR 21, 2026

APR 21, 2026

Investment

OrbiMed Advisors — Activity | F4

Participated in Sidewinder Therapeutics' $137M Series B financing to advance next-generation bispecific ADCs for cancer.

Sidewinder Therapeutics

Sidewinder Therapeutics OrbiMed Advisors

sidewinderbio.comAPR 8, 2026

APR 8, 2026

Investment

Co-led $39.5M financing for Congruence Therapeutics to advance small molecule correctors into clinical trials.

Congruence Therapeutics

Congruence Therapeutics OrbiMed Advisors

prnewswire.comMAR 19, 2026

MAR 19, 2026